The success of Sildenafil initially drove a period of growth for pharma, but recent shifts present a complicated scenario for investors. Off-patent competitors are eroding revenue, and persistent litigation add further https://adreavulh532484.suomiblog.com/viagra-and-the-pharmaceutical-industry-a-volatile-play-57007419